Is SHC or VCYT more undervalued in 2026?

CirclFi compares Sotera Health Company (SHC) and Veracyte, Inc. (VCYT) using 13 institutional-grade valuation models. SHC has a Quality of Company score of 8.7/10 while VCYT scores 8.8/10.

Which is a better buy — SHC or VCYT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SHC and VCYT valuations compare?

SHC at $15.75 and VCYT at $47.99 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SHC vs VCYT Valuation Comparison 2026 — Intrinsic Value Analysis

SHC

Diagnostics & Research

Sotera Health Company

Quality

8.7

out of 10

Value Trap

—

Price

$15.75

Last close

Models

11/13

Active

VCYT

Diagnostics & Research

Veracyte, Inc.

Quality

8.8

out of 10

Value Trap

SAFE

Price

$47.99

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	SHC Fair Value	SHC Upside	VCYT Fair Value	VCYT Upside
Bayesian DCF	Intrinsic	$8.84	-43.5%	$27.76	-42.1%
Earnings Power Value	Intrinsic	—	—	$12.66	-73.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$2.21	-85.8%	$3.10	-91.0%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SHC vs VCYT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SHC vs VCYT — Which Stock Is More Undervalued?

VCYT scores higher with a 8.8/10 quality rating vs SHC's 8.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Sotera Health Company (SHC) and Veracyte, Inc. (VCYT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SHC currently trades at $15.75 with a QOC of 8.7/10, while VCYT trades at $47.99 with a QOC of 8.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).